|
2011ǯ6·î27Æü¡¢ÊƹñϢˮºÇ¹âºÛȽ½ê¤Ï¡¢Caraco Pharmaceutical Laboratories Ltd. v. Novo Nordisk A/S¡ÊHatch-Waxman Act¤Ë´Ø¤¹¤ëÌäÂê¡Ë»ö·ï¤ª¤è¤ÓKappos v. Hyatt»ö·ï (ÊÆ¹ñÆÃµöË¡Âè145¾ò¤Ë´ð¤Å¤¯DCÃϺۤؤιµÁʤǤξڵò¤Ë´Ø¤¹¤ëÌäÂê¡Ë¤Ç¤Î¾å¹ð¤ò¤ß¤È¤á¿³Íý¤¹¤ë¤³¤È¤ò·èÄꤷ¤Þ¤·¤¿¡£ |
Á´ÂÎɽ¼¨
[ ¥ê¥¹¥È | ¾ÜºÙ ]
|
ÀèȯÌÀ¼çµÁ¤«¤éÀè½Ð´ê¼çµÁ¤Ø¤Î°Ü¹Ô¤Ë´Ø¤¹¤ëµ¬Äê¤ò´Þ¤àÊÆ¹ñÆÃµöˡˡ°ÆH.R.1249¤¬²¼±¡¤òÄ̲ᤤ¤¿¤·¤Þ¤·¤¿¡£ |
|
ÊÆ¹ñºÇ¹âºÛȽ½ê¤¬¡¢ÊƹñÆÃµöË¡Âè271¾ò(b)¤Ëµ¬Äꤵ¤ì¤ë¿¯³²¶µº¶¤ÎȽÃÇ´ð½à¤ò¿·¤¿¤Ë¼¨¤·¤Þ¤·¤¿¤Î¤Ç¤ªÃΤ餻¤¤¤¿¤·¤Þ¤¹¡£ |
|
¿¯³²¶µº¶¤Ë´Ø¤¹¤ëÊÆ¹ñºÇ¹âºÛȽ½êȽ·è¤¬¤Ç¤Þ¤·¤¿¡£ |
|
´ë¶È¤Î¼Â̳¤ËÂ礤¯±Æ¶Á¤¹¤ëInequitable Conduct¤Ë´Ø¤¹¤ëTherasense v. BeconÂçË¡ÄîȽ·è¤¬½Ð¤Þ¤·¤¿¤Î¤Ç¤ªÃΤ餻¤¤¤¿¤·¤Þ¤¹¡£ |





